Simplex Trading’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.3K | Buy |
+169
| New | +$31.8K | ﹤0.01% | 6646 |
|
|
2026
Q1 | – | Sell |
-125
| Closed | -$23.7K | – | 9050 |
|
|
2025
Q4 | $23.7K | Buy |
+125
| New | +$23.1K | ﹤0.01% | 6321 |
|
|
2025
Q2 | – | Sell |
-474
| Closed | -$74K | – | 8623 |
|
|
2025
Q1 | $74K | Buy |
474
+238
| +101% | +$38.6K | ﹤0.01% | 5389 |
|
|
2024
Q4 | $37K | Buy |
+236
| New | +$39.7K | ﹤0.01% | 6167 |
|
|
2022
Q2 | – | Sell |
-1,548
| Closed | -$250K | – | 9935 |
|
|
2022
Q1 | $250K | Buy |
1,548
+1,405
| +983% | +$228K | ﹤0.01% | 4807 |
|
|
2021
Q4 | $27K | Buy |
+143
| New | +$27.6K | ﹤0.01% | 8024 |
|
|
2021
Q2 | – | Sell |
-124
| Closed | -$21K | – | 10016 |
|
|
2021
Q1 | $21K | Sell |
124
-700
| -85% | -$127K | ﹤0.01% | 7406 |
|
|
2020
Q4 | $139K | Buy |
+824
| New | +$136K | ﹤0.01% | 5075 |
|
|
2020
Q3 | – | Sell |
-663
| Closed | -$108K | – | 7776 |
|
|
2020
Q2 | $108K | Buy |
+663
| New | +$101K | ﹤0.01% | 4716 |
|
|
2020
Q1 | – | Sell |
-233
| Closed | -$32K | – | 7578 |
|
|
2019
Q4 | $32K | Buy |
233
+206
| +763% | +$27.1K | ﹤0.01% | 5594 |
|
|
2019
Q3 | $3K | Sell |
27
-6,618
| -100% | -$823K | ﹤0.01% | 6775 |
|
|
2019
Q2 | $857K | Sell |
6,645
-360
| -5% | -$44.4K | ﹤0.01% | 2045 |
|
|
2019
Q1 | $900K | Buy |
+7,005
| New | +$885K | ﹤0.01% | 2085 |
|
|
2018
Q3 | – | Sell |
-1,245
| Closed | -$149K | – | 7391 |
|
|
2018
Q2 | $149K | Buy |
1,245
+965
| +345% | +$114K | ﹤0.01% | 3817 |
|
|
2018
Q1 | $33K | Buy |
+280
| New | +$35.1K | ﹤0.01% | 2842 |
|
|
2017
Q4 | – | Sell |
-702
| Closed | -$94K | – | 5972 |
|
|
2017
Q3 | $94K | Buy |
+702
| New | +$91.4K | ﹤0.01% | 1752 |
|
|
2017
Q1 | – | Sell |
-140
| Closed | -$15K | – | 6126 |
|
|
2016
Q4 | $15K | Buy |
140
+11
| +9% | +$1.2K | ﹤0.01% | 3298 |
|
|
2016
Q3 | $14K | Sell |
129
-120
| -48% | -$13.7K | ﹤0.01% | 3300 |
|
|
2016
Q2 | $25K | Sell |
249
-376
| -60% | -$40.1K | ﹤0.01% | 2696 |
|
|
2016
Q1 | $64K | Sell |
625
-537
| -46% | -$56K | 0.01% | 1740 |
|
|
2015
Q4 | $147K | Buy |
+1,162
| New | +$142K | 0.01% | 1086 |
|
|
2015
Q3 | – | Sell |
-500
| Closed | -$67K | – | 5483 |
|
|
2015
Q2 | $67K | Buy |
500
+258
| +107% | +$34.3K | 0.01% | 1462 |
|
|
2015
Q1 | $31K | Sell |
242
-76
| -24% | -$9.55K | ﹤0.01% | 1928 |
|
|
2014
Q4 | $37K | Buy |
+318
| New | +$35.8K | ﹤0.01% | 1577 |
|
Other funds holding BBH
MIM
CCA
BFG
Simplex Trading's BBH Position: Q2 2026 in Review
Simplex Trading opened a new position in VanEck Biotech ETF (BBH) in Q2 2026: 169 shares worth $34.3K. The stake represents ﹤0.01% of the portfolio and ranks #6646 among its holdings. This is a return to the name: Simplex Trading previously reported a position in BBH as recently as Q4 2025.
Simplex Trading first reported a position in BBH in Q4 2014 and has held it in 24 quarters since. The position peaked at $900K in Q1 2019. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.
- Simplex Trading held 169 shares of VanEck Biotech ETF worth $34.3K as of Q2 2026.
- VanEck Biotech ETF was a new Simplex Trading position in Q2 2026.
- VanEck Biotech ETF made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6646 holding.
- Simplex Trading first reported a position in VanEck Biotech ETF in Q4 2014 and has held it in 24 quarters since.
- Simplex Trading's VanEck Biotech ETF position peaked at $900K in Q1 2019.
- 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.